[Seite 62↓]


Akira, S. (2003). Mammalian Toll-like receptors. Curr Opin Immunol 15, 5-11.

Akira, S., Taga, T., and Kishimoto, T. (1993). Interleukin-6 in biology and medicine. Adv Immunol 54, 1-78.

Alexander, C., and Rietschel, E. T. (2001). Bacterial lipopolysaccharides and innate immunity. J Endotoxin Res 7, 167-202.

Appelmelk, B. J., An, Y. Q., Geerts, M., Thijs, B. G., de Boer, H. A., MacLaren, D. M., de Graaff, J., and Nuijens, J. H. (1994). Lactoferrin is a lipid A-binding protein. Infect Immun 62, 2628-32.

Arbour, N. C., Lorenz, E., Schutte, B. C., Zabner, J., Kline, J. N., Jones, M., Frees, K., Watt, J. L., and Schwartz, D. A. (2000). TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25, 187-91.

Battafaraono, R. J., Dahlberg, P. S., Ratz, C. A., Johnston, J. W., Gray, B. H., Haseman, J. R., Mayo, K. H., and Dunn, D. L. (1995). Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro. Surgery 118, 318-24.

Baumann, H., and Gauldie, J. (1994). The acute phase response. Immunol Today 15, 74-80.

Baumgartner, J. D. (1990). Monoclonal anti-endotoxin antibodies for the treatment of gram-negative bacteremia and septic shock. Eur J Clin Microbiol Infect Dis 9, 711-6.

Bazil, V., and Strominger, J. L. (1991). Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. J Immuno 147, 1567-74.

Beamer, L. J., Carroll, S. F., and Eisenberg, D. (1998). The BPI/LBP family of proteins: a structural analysis of conserved regions. Protein Sci 7, 906-14.

[Seite 63↓]

Beamer, L. J., Carroll, S. F., and Eisenberg, D. (1997). Crystal structure of human BPI and two bound phospholipids at 2.4 angstrom resolution. Science 276, 1861-4.

Belvin, M. P., and Anderson, K. V. (1996). A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu Rev Cell Dev Biol 12, 393-416.

Berger, D., and Beger, H. G. (1987). Evidence for endotoxin binding capacity of human Gc-globulin and transferrin. Clin Chim Acta 163, 289-99.

Bernard, G. R., Vincent, J. L., Laterre, P. F. (2001). Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344, 699-709.

Bone, R. C. (1991). The pathogenesis of sepsis. Ann Intern Med 115, 457-69.

Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M., and Sibbald, W. J. (1992). Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest PHysicians/Society of Critical Care Medicine. Chest 101, 1644-55.

Brun-Buisson, C. (2000). The epidemiology of the systemic inflammatory response. Intensive Care Med 26, 64-74.

Chen, C., Brock, R., Luh, F., Chou, P. J., Larrick, J. W., Huang, R. F., and Huang, T. H. (1995). The solution structure of the active domain of CAP18--a lipopolysaccharide binding protein from rabbit leukocytes. FEBS Lett 370, 46-52.

Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., and Gusovsky, F. (1999). Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274, 10689-92.

Cohen, J., and Glauser, M. P. (1991). Septic shock: treatment. Lancet 338, 736-9.

Dankesreiter, S., Hoess, A., Schneider-Mergener, J., Wagner, H., and Miethke, T. (2000). Synthetic endotoxin-binding peptides block endotoxin-triggered TNF- alpha production by macrophages in vitro and in vivo and prevent endotoxin-mediated toxic shock. J Immunol 164, 4804-11.

[Seite 64↓]

Danner, R. L., Elin, R. J., Hosseini, J. M., Wesley, R. A., Reilly, J. M. and Parillo, J. E. (1991). Endotoxin in human septic shock. Chest 99, 169-75.

David, S. A. (2001). Towards a rational development of anti-endotoxin agents: novel approaches to sequestration of bacterial endotoxins with small molecules. J Mol Recognit 14, 370-87.

Day, J. R., Albers, J. J., Lofton-Day, C. E., Gilbert, T. L., Ching, A. F., Grant, F. J., O'Hara, P. J., Marcovina, S. M., and Adolphson, J. L. (1994). Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. J Biol Chem 269, 9388-91.

de Haas, C. J., van der Tol, M. E., Van Kessel, K. P., Verhoef, J., and Van Strijp, J. A. (1998). A synthetic lipopolysaccharide-binding peptide based on amino acids 27- 39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood. J Immunol 161, 3607-15.

Dellinger, R. P. (2003). Cardiovascular management of septic shock. Crit Care Med 31, 946-52.

De Visser, P. C., Kriek, N. M., van Hooft, P. A., Van Schepdael, A., Filippov, D. V., van der Marel, G. A., Overkleeft, H. S., van Boom, J. H. and Noort, D. (2003). Solid-phase synthesis of polymyxin B1 and analogues via a safety-catch approach. J Pert Res 61,:6 298-306.

Dinarello, C. A. (2000). Proinflammatory cytokines. Chest 118, 503-8.

Dinarello, C. A., and Wolff, S. M. (1993). The role of interleukin-1 in disease. N Engl J Med 328, 106-13.

Doolittle, R. F. (1984). Fibrinogen and fibrin. Annu Rev Biochem 53, 195-229.

Drayna, D., Jarnagin, A. S., McLean, J., Henzel, W., Kohr, W., Fielding, C., and Lawn, R. (1987). Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 327, 632-4.

[Seite 65↓]

Durieux, J. J., Vita, N., Popescu, O., Guette, F., Calzada-Wack, J., Munker, R., Schmidt, R. E., Lupker, J., Ferrara, P., Ziegler-Heitbrock, H. W., and et al. (1994). The two soluble forms of the lipopolysaccharide receptor, CD14: characterization and release by normal human monocytes. Eur J Immunol 24, 2006-12.

Elsbach, P., and Weiss, J. (1993). The bactericidal/permeability-increasing protein (BPI), a potent element in host-defense against gram-negative bacteria and lipopoly­saccharide. Immunobiology 187, 417-29.

Fearon, D. T., and Locksley, R. M. (1996). The instructive role of innate immunity in the acquired immune response. Science 272, 50-3.

Frey, E. A., Miller, D. S., Jahr, T. G., Sundan, A., Bazil, V., Espevik, T., Finlay, B. B., and Wright, S. D. (1992). Soluble CD14 participates in the response of cells to lipopoly­saccharide. J Exp Med 176, 1665-71.

Friedman, G., Silva, E., and Vincent, J. L. (1998). Has the mortality of septic shock changed with time. Crit Care Med 26, 2078-86.

Gabay, C. and Kushner, I. (1999). Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340, 448-53.

Gauldie, J., Northemann, W., and Fey, G. H. (1990). IL-6 functions as an exocrine hormone in inflammation. Hepatocytes undergoing acute phase responses require exogenous IL-6. J Immunol 144, 3804-8.

Gazzano-Santoro, H., Parent, J. B., Grinna, L., Horwitz, A., Parsons, T., Theofan, G., Elsbach, P., Weiss, J., and Conlon, P. J. (1992). High-affinity binding of the bacteri­cidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide. Infect Immun 60, 4754-61.

Gegner, J. A., Ulevitch, R. J., and Tobias, P. S. (1995). Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane. CD14 J Biol Chem 270, 5320-5.

[Seite 66↓]

Ghosh, S., May, M. J., and Kopp, E. B. (1998). NF-kappa B and Rel proteins: evolutio­ narily conserved mediators of immune responses. Annu Rev Immunol 16, 225-60.

Glauser, M. P., Zanetti, G., Baumgartner, J. D., and Cohen, J. (1991). Septic shock: pathogenesis. Lancet 338, 732-6.

Gray, P. W., Flaggs, G., Leong, S. R., Gumina, R. J., Weiss, J., Ooi, C. E., and Elsbach, P. (1989). Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations. J Biol Chem 264, 9505-9.

Guha, M., and Mackman, N. (2001). LPS induction of gene expression in human mono­cytes. Cell Signal 13, 85-94.

Guha, M., O'Connell, M. A., Pawlinski, R., Hollis, A., McGovern, P., Yan, S. F., Stern, D., and Mackman, N. (2001). Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor alpha expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98, 1429-39.

Hack, C. E., Aarden, L. A., and Thijs, L. G. (1997). Role of cytokines in sepsis. Adv Immunol 66, 101-95.

Hailman, E., Albers, J. J., Wolfbauer, G., Tu, A. Y., and Wright, S. D. (1996). Neutra­lization and transfer of lipopolysaccharide by phospholipid transfer protein. J Biol Chem 271, 12172-8.

Hailman, E., Lichenstein, H. S., Wurfel, M. M., Miller, D. S., Johnson, D. A., Kelley, M., Busse, L. A., Zukowski, M. M., and Wright, S. D. (1994). Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J Exp Med 179, 269-77.

Hamann, L., Stamme, C., Ulmer, A. J. and Schumann, R. R. (2002). Biochem Biophys Res Commun 295, 553-60.

Hancock, R. E. (1997). Peptide antibiotics. Lancet 349, 418-22.

Hancock, R. E. and Scott, M. G. (2000). The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci USA 97, 8856-61.

[Seite 67↓]

Harris, H. W., Grunfeld, C., Feingold, K. R., and Rapp, J. H. (1990). Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest 86, 696-702.

Hart, P. H., Jones, C. A. and Finlay, J. J. (1992). Interleukin-4 suppression of monocyte tumor necrosis-alpha production. Dependence on protein synthesis but not cyclic AMP production. Immunology 76, 560-5.

Haziot, A., Chen, S., Ferrero, E., Low, M. G., Silber, R., and Goyert, S. M. (1988). The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. J Immunol 141, 547-52.

Haziot, A., Rong, G. W., Silver, J., and Goyert, S. M. (1993). Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. J Immunol 151, 1500-7.

Heiman, D. F., Astiz, M. E., Rackow, E. C., Rhein, D., Kim, Y. B., and Weil, M. H. (1990). Monophosphoryl lipid A inhibits neutrophil priming by lipopolysaccharide. J Lab Clin Med 116, 237-41.

Hewett, J. A., and Roth, R. A. (1993 ). Hepatic and extrahepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev 45, 382-411.

Hoess, A., Watson, S., Siber, G. R., and Liddington, R. (1993). Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. Embo J 12, 3351-6.

Höflich, C. und Volk, H.-D. (2002). Immunmodulation in der Sepsis. Chirurg 73, 1100-4.

Holst, O., and Brade, H. (1992). Chemical structure of the core region of Lipopoly­saccharides. In Bacterial Endotoxic Lipopolysaccharides, Volume 1, D. C. Morrison and J. L. Ryan, eds (Boca Raton, Ann Arbor, London, Tokyo: CRC Pres). 136-70.

Hotchkiss, R. S., and Karl, I. E. (2003). The pathophysiology and treatment of sepsis. N Engl J Med 348, 138-50.

[Seite 68↓]

Janeway, C. A., Jr. (1989). Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol 54, 1-13.

Janeway, C. A., Jr., and Medzhitov, R. (2002). Innate immune recognition. Annu Rev Immunol 20, 197-216.

Janeway, C. A., Travers, P., Walport, M. and Copra, J. D. (1999). Immunobiology. The immune system in health and disease. Current Biology Ltd./Garland Publishing Inc. London.

Kalsheker, N. A. (1996). Alpha 1-antichymotrypsin. Int J Biochem Cell Biol 28, 961-4.

Karin, M., and Ben-Neriah, Y. (2000). Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18, 621-63.

Kirschning, C. J., Au-Young, J., Lamping, N., Reuter, D., Pfeil, D., Seilhamer, J. J., and Schumann, R. R. (1997). Similar organization of the lipopolysaccharide-binding protein (LBP) and phospholipid transfer protein (PLTP) genes suggests a common gene family of lipid-binding proteins. Genomics 46, 416-25.

Kirschning, C. J., Wesche, H., Merrill Ayres, T., and Rothe, M. (1998). Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188, 2091-7.

Kodama, T., Freeman, M., Rohrer, L., Zabrecky, J., Matsudaira, P., and Krieger, M. (1990). Type I macrophage scavenger receptor contains alpha-helical and collagen-like coiled coils. Nature 343, 531-5.

Kox, W. J., Volk, T., Kox, S. N. and Volk, H.-D. (2000). Immunmodulatory therapies in Sepsis. Intensiv Care Med 26, 124-28.

Krauss, J. H., Seydel, U., Weckesser, J., and Mayer, H. (1989). Structural analysis of the nontoxic lipid A of Rhodobacter capsulatus 37b4. Eur J Biochem 180, 519-26.

Kushner, I. (1993). Regulation of the acute phase response by cytokines Perspect. Biol Med 36. 611-22.

[Seite 69↓]

Kushner, I., and Mackiewicz, A. (1987). Acute phase proteins as disease markers. Dis Markers 5, 1-11.

Lamping, N., Hoess, A., Yu, B., Park, T. C., Kirschning, C. J., Pfeil, D., Reuter, D., Wright, S. D., Herrmann, F., and Schumann, R. R. (1996). Effects of site-directed muta­genesis of basic residues (Arg 94, Lys 95, Lys 99) of lipopolysaccharide (LPS)-binding protein on binding and transfer of LPS and subsequent immune cell activation. J Immunol 157, 4648-56.

Larrick, J. W., Morgan, J. G., Palings, I., Hirata, M., and Yen, M. H. (1991). Comple­mentary DNA sequence of rabbit CAP18--a unique lipopolysaccharide binding protein. Biochem Biophys Res Commun 179, 170-5.

Lemaitre, B., Nicolas, E., Michaut, L., Reichhart, J. M., and Hoffmann, J. A. (1996). The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86, 973-83.

Lemaitre, B., Reichhart, J. M., and Hoffmann, J. A. (1997). Drosophila host defense: differential induction of antimicrobial peptide genes after infection by various classes of microorganisms. Proc Natl Acad Sci U S A 94, 14614-9.

Lepper, P. M., Held, T. K., Schneider, E. M., Bolke, E., Gerlach, H., and Trautmann, M. (2002). Clinical implications of antibiotic-induced endotoxin release in septic shock. Intensive Care Med 28, 824-33.

Levin, J., Poore, T. E., Young, N. S., Margolis, S., Zauber, N. P., Townes, A. S., and Bell, W. R. (1972). Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement. Ann Intern Med 76, 1-7.

Levin, M., Quint, P. A., Goldstein, B., Barton, P., Bradley, J. S., Shemie, S. D., Yeh, T., Kim, S. S., Cafaro, D. P., Scannon, P. J. and Giroir, B. P. (2000). Recombinant bacteri­cidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI2 meningococcal sepsis study group. Lancet 356, 961-7.

[Seite 70↓]

Liu, M. K., Herrera-Velit, P., Brownsey, R. W., and Reiner, N. E. (1994). CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. J Immunol 153, 2642-52.

Loppnow, H., Stelter, F., Schonbeck, U., Schluter, C., Ernst, M., Schutt, C., and Flad, H. D. (1995). Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect Immun 63, 1020-6.

Martin, G. S., Mannino, D. M., Eaton, S. and Moss, M. (2003). Epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348, 1546-54.

Matot, I., and Sprung, C. L. (2001). Definition of sepsis. Intensive Care Med 27, 3-9.

Matthay, M. A. (2001). Severe sepsis : a new treatment with both anticoagulant and antiinflammatory properties. N Engl J Med 344, 759-62.

McCafferty, D. G., Cudic, P., Frankel, B. A., Barkallah, S., Kruger, R. G. and Li, W. (2002). Chemistry and biology of the ramoplanin family of peptide antibiotics. Biopo­ly­mers 66:4, 261-84.

Medzhitov, R., and Janeway, C., Jr. (2000). Innate immune recognition: mechanisms and pathways. Immunol Rev 173, 89-97.

Medzhitov, R., and Janeway, C. A., Jr. (1998). An ancient system of host defense. Curr Opin Immunol 10, 12-5.

Medzhitov, R., and Janeway, C. A., Jr. (1997). Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9, 4-9.

Medzhitov, R., and Janeway, C. A., Jr. (1998). Self-defense: the fruit fly style. Proc Natl Acad Sci U S A 95, 429-30.

Medzhitov, R., Preston-Hurlburt, P., and Janeway, C. A., Jr. (1997). A human homo­logue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388, 394-7.

[Seite 71↓]

Moldawer, L. L. (1994). Biology of proinflammatory cytokines and their antagonists. Crit Care Med 22, 3-7.

Moore, K. W., O'Garra, A., de Waal Malefyt, R., Vieira, P., and Mosmann, T. R. (1993). Interleukin-10. Annu Rev Immunol 11, 165-90.

Morita, T., Ohtsubo, S., Nakamura, T., Tanaka, S., Iwanaga, S., Ohashi, K., and Niwa, M. (1985). Isolation and biological activities of limulus anticoagulant (anti-LPS factor) which interacts with lipopolysaccharide (LPS). J Biochem (Tokyo) 97, 1611-20.

Muta, T., Miyata, T., Tokunaga, F., Nakamura, T., and Iwanaga, S. (1987). Primary structure of anti-lipopolysaccharide factor from American horseshoe crab, Limulus polyphemus. J Biochem (Tokyo) 101, 1321-30.

Nathan, C. F. (1987). Secretory products of macrophages. J Clin Invest 79, 319-26.

Nathanson, C., Hoffman, W. D., Suffredini, A. F., Eichacker, P. Q. and Danner, R. L. (1994). Selected treatment strategies for septic shock based on proposed mechanism of pathogenesis. Ann Internal Med 120, 771-83.

Netea, M. G., Demacker, P. N., Kullberg, B. J., Jacobs, L. E., Verver-Jansen, T. J., Boerman, O. C., Stalenhoef, A. F., and Van der Meer, J. W. (1998). Bacterial lipopoly­saccharide binds and stimulates cytokine-producing cells before neutralization by endo­genous lipoproteins can occur. Cytokine 10, 766-72.

Opal, S. M., Palardy, J. E., Marra, M. N., Fisher, C. J., Jr., McKelligon, B. M., and Scott, R. W. (1994). Relative concentrations of endotoxin-binding proteins in body fluids during infection. Lancet 344, 429-31.

Parillo, E. J. (1993). Pathogenetic mechanisms of septic shock. N Engl J Med 328, 1471-78.

Poltorak, A., He, X., Smirnova, I., Liu, M. Y., Van Huffel, C., Du, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciardi-Castagnoli, P., Layton, B., and Beutler, B. (1998). Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-8.

[Seite 72↓]

Pugin, J., Schurer-Maly, C. C., Leturcq, D., Moriarty, A., Ulevitch, R. J., and Tobias, P. S. (1993). Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci U S A 90, 2744-8.

Raetz, C. R. (1990). Biochemistry of endotoxins. Annu Rev Biochem 59, 129-70.

Rangel-Frausto, M. S., Pittet, D., Costigan, M., Hwang, T., Davis, C. S., and Wenzel, R. P. (1995). The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273, 117-23.

Ried, C., Wahl, C., Miethke, T., Wellnhofer, G., Landgraf, C., Schneider-Mergener, J., and Hoess, A. (1996). High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus anti-lipopolysaccharide factor. J Biol Chem 271, 28120-7.

Rietschel, E. T., Brade, H., Brade, L., Brandenburg, K., Schade, U., Seydel, U., Zahringer, U., Galanos, C., Luderitz, O., Westphal, O. (1987). Lipid A, the endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to biological activity. Prog Clin Biol Res 231, 25-53.

Rietschel, E. T., Brade, H., Holst, O., Brade, L., Muller-Loennies, S., Mamat, U., Zahringer, U., Beckmann, F., Seydel, U., Brandenburg, K., Ulmer, A. J., Mattern, T., Heine, H., Schletter, J., Loppnow, H., Schonbeck, U., Flad, H. D., Hauschildt, S., Schade, U. F., Di Padova, F., Kusumoto, S., and Schumann, R. R. (1996). Bacterial endotoxin: Chemical constitution, biological recognition, host response, and immuno­logical detoxification. Curr Top Microbiol Immunol 216, 39-81.

Rietschel, E. T., Kirikae, T., Schade, F. U., Mamat, U., Schmidt, G., Loppnow, H., Ulmer, A. J., Zahringer, U., Seydel, U., Di Padova, F. (1994). Bacterial endotoxin: molecular relationships of structure to activity and function. Faseb J 8, 217-25.

Rivers, E., Nguyen, B., Havstad, S., Ressler, J., Muzzin, A., Knoblich, B., Peterson, E. and Tomlanovich, M. (2001). Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345, 1368-77.

[Seite 73↓]

Robert, P. Y. and Adenis J. P. (2001). Comparative review of the ophthalmic anti­bacterial preparations. Drugs 61:2, 175-85.

Rock, F. L., Hardiman, G., Timans, J. C., Kastelein, R. A., and Bazan, J. F. (1998). A family of human receptors structurally related to Drosophila Toll. Proc Natl Acad Sci USA 95, 588-93.

Roth, R. I., Su, D., Child, A. H., Wainwright, N. R., and Levin, J. (1998). Limulus anti­lipopolysaccharide factor prevents mortality late in the course of endotoxemia. J Infect Dis 177, 388-94.

Schumann, R. R., Kirschning, C. J., Unbehaun, A., Aberle, H. P., Knope, H. P., Lamping, N., Ulevitch, R. J., and Herrmann, F. (1996). The lipopolysaccharide-binding protein is a secretory class 1 acute- phase protein whose gene is transcriptionally activated by APRF/STAT/3 and other cytokine-inducible nuclear proteins. Mol Cell Biol 16, 3490-503.

Schumann, R. R., Lamping, N. and Hoess, A. (1997). Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities. J Immunol 159, 5599-605.

Schumann, R. R., Leong, S. R., Flaggs, G. W., Gray, P. W., Wright, S. D., Mathison, J. C., Tobias, P. S., and Ulevitch, R. J. (1990). Structure and function of lipopoly­saccharide binding protein. Science 249, 1429-31.

Schumann, R. R., Rietschel, E. T. and Loppnow, H. (1994). The role of CD14 and lipopolysacchareide-binding protein (LBP) in the activation of different cell types by endotoxin. Med Microbiol Immunol 183, 279-97.

Seydel, U., Labischinski, H., Kastowsky, M., and Brandenburg, K. (1993). Phase behavior, supramolecular structure, and molecular conformation of lipopolysaccharide. Immunobiology 187, 191-211.

Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., and Kimoto, M. (1999). MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll- like receptor 4. J Exp Med 189, 1777-82.

[Seite 74↓]

Steel, D. M., and Whitehead, A. S. (1994). The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15, 81-8.

Suffredini, A. F., Fantuzzi, G., Badolato, R., Oppenheim, J. J., and O'Grady, N. P. (1999). New insights into the biology of the acute phase response. J Clin Immunol 19, 203-14.

Takada, K., Ohno, N., and Yadomae, T. (1994). Binding of lysozyme to lipopoly­sac­charide suppresses tumor necrosis factor production in vivo. Infect Immun 62, 1171-5.

Takeda, K., Kaisho, T. and Akira, S. (2003). Toll-like receptors. Annu Rev Immunol 21, 335-76.

Takayama, K., Mitchell, D. H., Din, Z. Z., Mukerjee, P., Li, C., and Coleman, D. L. (1994). Monomeric Re lipopolysaccharide from Escherichia coli is more active than the aggregated form in the Limulus amebocyte lysate assay and in inducing Egr-1 mRNA in murine peritoneal macrophages. J Biol Chem 269, 2241-4.

Tall, A. (1995). Plasma lipid transfer proteins. Annu Rev Biochem 64, 235-57.

Tanaka, S., Nakamura, T., Morita, T., and Iwanaga, S. (1982). Limulus anti-LPS factor: an anticoagulant which inhibits the endotoxin mediated activation of Limulus coagu­lation system. Biochem Biophys Res Commun 105, 717-23.

Tobias, P. S., Mathison, J. C., and Ulevitch, R. J. (1988). A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J Biol Chem 263, 13479-81.

Tsai, E. Y., Falvo, J. V., Tsytsykova, A. V., Barczak, A. K., Reimold, A. M., Glimcher, L. H., Fenton, M. J., Gordon, D. C., Dunn, I. F., and Goldfeld, A. E. (2000). A lipopoly­saccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor alpha promoter in vivo. Mol Cell Biol 20, 6084-94.

[Seite 75↓]

Vallespi, M. G., Alvarez-Obregon, J. C., Rodriguez-Alonso, I., Montero, T., Garay, H., Reyes, O., and Arana, M. J. (2003). A Limulus anti-LPS factor-derived peptide modu­lates cytokine gene expression and promotes resolution of bacterial acute infection in mice. Int Immunopharmacol 3, 247-56.

Vallespi, M. G., Glaria, L. A., Reyes, O., Garay, H. E., Ferrero, J., and Arana, M. J. (2000). A Limulus antilipopolysaccharide factor-derived peptide exhibits a new immunological activity with potential applicability in infectious diseases. Clin Diagn Lab Immunol 7, 669-75.

Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P. and Bouillon, R. (2001). Intensive insulin therapy in critical ill patients. N Engl J Med 345, 1359-67.

van der Bruggen, T., Nijenhuis, S., van Raaij, E., Verhoef, J., and van Asbeck, B. S. (1999). LPS-induced tumor necrosis factor alpha production by human monocytes involves the raf-1/MEK1-MEK2/ERK1-ERK2 pathway. Infect Immun 67, 3824-9.

van der Poll, T., and van Deventer, S. J. (1999). Cytokines and anticytokines in the pathogenesis of sepsis. Infect Dis Clin North Am 13, 413-26.

Van Lenten, B. J., Fogelman, A. M., Haberland, M. E., and Edwards, P. A. (1986). The role of lipoproteins and receptor-mediated endocytosis in the transport of bacterial lipopolysaccharide. Proc Natl Acad Sci USA 83, 2704-8.

Vassalli, P. (1992). The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10, 411-52.

Vilcek, J., and Lee, T. H. (1991). Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266, 7313-6.

Vincent, J. L. (1998). Search for effective immunomodulating strategies against sepsis. Lancet 351, 922-3.

Vincent, J. L., Sun, Q., and Dubois, M. J. (2002). Clinical trials of immunomodulatory therapies in severe sepsis and septic shock. Clin Infect Dis 34, 1084-93.

[Seite 76↓]

Volk, H.-D., Reinke, P. and Docke, W. D. (2000). Clinical aspects: from systemic inflammation to ‚immunparalysis‘. Chem Immunol 74, 162-77.

Wainwright, N. R., Miller R. J., and Paus, E. (1990). Endotoxin binding and neutralizing activity by a protein from Limulus polyphemus. In: Nowotny A., Spitzer J., Ziegler E. eds (Cellular and molecular aspects of endotoxin reactions. Amsterdam: Elsevier) 315-25.

Warren, H. S., Suffredini, A. F., Eichacker, P. Q. and Munford, R. S. (2002). Risks and benefits of activated protein C treatment for severe sepsis. N Engl J Med 347, 1027-30.

Warren, H. S., Glennon, M. L., Wainwright, N., Amato, S. F., Black, K. M., Kirsch, S. J., Riveau, G. R., Whyte, R. I., Zapol, W. M., and Novitsky, T. J. (1992). Binding and neutralization of endotoxin by Limulus antilipopolysaccharide factor. Infect Immun 60, 2506-13.

Weiss, C. A., 3rd, Wasiluk, K. R., Kellogg, T. A., and Dunn, D. L. (2000). Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopoly­saccharide factor. Surgery 128, 339-44.

Weiss, J. (2003). Bactericidal/permeability-increasing protein (BPI) and lipopoly­saccharide-binding protein (LBP): structure, function and regulation in host defense against Gram-negative bacteria. Biochem Soc Trans 31, 785-89.

Wright, S. D. and Jong, M. T. C. (1986). Adhesion-promoting receptors on human macrophages recognize E. coli by binding to Lipopolysaccharide. J Exp Med 164, 1876-88.

Wright, S. D., Ramos, R. A., Tobias, P. S., Ulevitch, R. J., and Mathison, J. C. (1990). CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249, 1431-3.

Wurfel, M. M., Hailman, E., and Wright, S. D. (1995). Soluble CD14 acts as a shuttle in the neutralization of lipopolysaccharide (LPS) by LPS-binding protein and reconstituted high density lipoprotein. J Exp Med 181, 1743-54.

[Seite 77↓]

Wurfel, M. M., Kunitake, S. T., Lichenstein, H., Kane, J. P., and Wright, S. D. (1994). Lipopolysaccharide (LPS)-binding protein is carried on lipoproteins and acts as a cofactor in the neutralization of LPS. J Exp Med 180, 1025-35.

Yu, B., Hailman, E., and Wright, S. D. (1997). Lipopolysaccharide binding protein and soluble CD14 catalyze exchange of phospholipids. J Clin Invest 99, 315-24.

Zeni, F., Freeman, B., and Natanson, C. (1997). Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 25, 1095-100.

Zhang, F. X., Kirschning, C. J., Mancinelli, R., Xu, X.-P., Jin, Y., Faure, E., Mantovani, A., Rothe, M., Muzio, M. and Arditi, M. (1999). Bacterial Lipopolysaccharide activates nuclear factor- κ B through Interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 274, 7611-4.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: